7.2

CVE-2024-11013: nec corporation univerge ix Command Injection

Deferred
Published 29-11-2024Last modified 24-07-2025

Vulnerability summary

CVE-2024-11013 is a high (CVSS 7.2) Command Injection vulnerability in nec corporation univerge ix. EPSS estimates a 1.10% chance of exploitation in the next 30 days, higher than 65.4% of scored vulnerabilities.

Overall risk
29/100
0100
Medium · default modelHow is this calculated?
CVSS score
7.2/10
010
High · v3.1 (CVE.org)
EPSS score
1.10%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits0No public exploits recorded

Timeline

  1. 29-11-2024
    PublishedVulnerability first disclosed.
  2. 24-07-2025
    Last modifiedVulnerability information updated.

Description

Command Injection vulnerability in NEC Corporation UNIVERGE IX from Ver9.2 to Ver10.10.21, for Ver10.8 up to Ver10.8.27, for Ver10.9 up to Ver10.9.14 and UNIVERGE IX-R/IX-V Ver1.2.15 and earlier allows a attacker to inject an arbitrary CLI commands to be executed on the device via the management interface.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

1.10%

Chance of exploitation in the next 30 days

Percentile

65%

Versus all other CVEs

30-day change

No change 0.00 pp

From 1.10% on 22-09-2026

22-09-202622-10-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

Nec corporation2 products

1 vendor · 2 products

References

1 links